ARCHIVES

FDA Requires Independent Confirmation of Disease Progression in Cooperative Group Trials; Seeks Documentation for Avastin in Breast Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 32 | September 15, 2006

Download PDF Visit The Full Archive

Related Articles

Estrogen-Only HRT Little Risk In Endometrial Cancer, GOG Study Indicates

March 26, 2004

SWOG Trial Reports Longest Survival To Date For NSCLC

June 29, 2001

New Report On Survival Data Available From NCI

July 25, 1975

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

DePinho Apologizes For Investment Advice: On CNBC He Recommended A Firm He Founded

June 1, 2012

Panel To Hear Centers’ Problems Again; Alabama, Mayo Impress Site visitors

March 18, 1977